These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2874389)

  • 1. Hydergine and reversibility of cyclosporin nephrotoxicity.
    Kho TL; Kengen R; Leunissen KM; Teule J; van Hooff JP
    Lancet; 1986 Aug; 2(8503):394-5. PubMed ID: 2874389
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydergine and cyclosporin nephrotoxicity.
    Nussenblatt RB; Austin HA; Palestine AG; Preuss HG
    Lancet; 1986 May; 1(8491):1220-1. PubMed ID: 2871464
    [No Abstract]   [Full Text] [Related]  

  • 3. Dihydroergotoxine (hydergine) to prevent cyclosporine nephrotoxicity in kidney transplant recipients.
    Vincent HH; Wenting GJ; Jeekel J; Schalekamp MA; Weimar W
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1737-8. PubMed ID: 3274419
    [No Abstract]   [Full Text] [Related]  

  • 4. Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients.
    Vanrenterghem Y; Waer M; De Keyser P; Roels L; Michielsen P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):615-7. PubMed ID: 3291296
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of hydergine on cyclosporine-induced nephrotoxicity in a rat kidney transplantation model.
    Singh SK; Ijzermans JN; Marquet RL; de Bruin RW; Westbroek DL; Jeekel J
    Transplantation; 1987 Apr; 43(4):593-5. PubMed ID: 3554650
    [No Abstract]   [Full Text] [Related]  

  • 6. Amelioration of preservation damage but not cyclosporine nephrotoxicity by dihydroergotoxine in kidney transplant recipients. A double-blind placebo-controlled trial.
    Brouwer ML; Wenting GJ; Vincent HH; Hendriks GF; Jeekel J; Weimar W
    Transplantation; 1989 Nov; 48(5):885-6. PubMed ID: 2815264
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of hydergine on cyclosporine-induced nephrotoxicity in kidney allografted rats.
    Ijzermans JN; Singh SK; de Bruin RW; Bouwman E; Weimar W; Marquet RL; Jeekel J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1385-6. PubMed ID: 3274337
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes, cyclosporin nephrotoxicity, and serum creatinine concentration.
    McNally PG; Feehally J; Walls J
    Diabet Med; 1991 Apr; 8(3):289. PubMed ID: 1828751
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cyclosporin-induced nephrotoxicity].
    Heering P; Grabensee B
    Dtsch Med Wochenschr; 1988 May; 113(20):833-4. PubMed ID: 3286182
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating cyclosporin nephrotoxicity.
    Kennedy MS
    Lancet; 1983 Oct; 2(8354):861. PubMed ID: 6137692
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotoxicity of cyclosporin A.
    Hows JM; Gordon-Smith EC
    Lancet; 1981 Oct; 2(8251):876-7. PubMed ID: 6116986
    [No Abstract]   [Full Text] [Related]  

  • 12. Dihydroergotoxine: 6-mg versus 3-mg dosage in the treatment of senile dementia. Preliminary report.
    Yesavage JA; Hollister LE; Burian E
    J Am Geriatr Soc; 1979 Feb; 27(2):80-2. PubMed ID: 762369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
    Piguet PV; Zoufal Z
    Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporin nephrotoxicity.
    Neild GH
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):198-203. PubMed ID: 2081228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of cyclosporin A in bone marrow transplant recipients.
    Gratwohl A; Müller M; Osterwalder B; Nissen C; Speck B
    Lancet; 1981 Sep; 2(8247):635. PubMed ID: 6116110
    [No Abstract]   [Full Text] [Related]  

  • 16. [A study of 93 cases of painful shoulder and shoulder-band syndrome treated with hydergine (author's transl)].
    Yaya Huamán R; Blasco Olcina R; García Fernández M; Vilches Padilla JJ
    Rev Esp Otoneurooftalmol Neurocir; 1975; 33(193):131-5. PubMed ID: 56021
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of oral hydergine (ergoloid mesylates) in alcohol related encephalopathy.
    Datta KD; Evenson RC; Gannon PJ; Dick EP
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):87-90. PubMed ID: 3299496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of organic psychosyndrome with hydergine and digitalis. A component study using double blind technics].
    Pfeiff E; Schlegel HE; Seus R; Dennler HJ; Kugler J
    Med Welt; 1980 Sep; 31(39):1403-7. PubMed ID: 7005587
    [No Abstract]   [Full Text] [Related]  

  • 19. Does nifedipine ameliorate cyclosporin A nephrotoxicity?
    Feehally J; Walls J; Mistry N; Horsburgh T; Taylor J; Veitch PS; Bell PR
    Br Med J (Clin Res Ed); 1987 Aug; 295(6593):310. PubMed ID: 3115427
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.